Leuko Raises $5 Million in Series A

BOSTON–(BUSINESS WIRE)–leukoan MIT startup that is developing PointCheck, the first solution to enable noninvasive home white…

Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients

BOSTON–(BUSINESS WIRE)–Leuko, an MIT startup developing PointCheckTM, the first solution to enable non-invasive home white blood…